Sarah Moreira 2019-09-10T09:15:47+00:00
Fundació Irsicaixa , Hospital Universitari Germans Trias i Pujol, Spain.
Julià Blanco (PhD in Biochemistry, University of Barcelona (UB), 1994) leads the Cell Virology and Immunology (VIC) group at IrsiCaixa. He has extensively studied the mechanisms involved in the immunological damage induced by HIV infection, including the analysis of the contribution of virological and immunological factors to CD4 T cell depletion, CD8 T cell hyper activation, immune exhaustion and B cell function. Dr. Blanco recently co-founded AlbaJuna Therapeutics SL as an IrsiCaixa spin-off whose main activity is the development of synthetic antibodies against HIV.